Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo

Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo

Abstract Background Ceftazidime-avibactam (CZA) improves treatment outcomes for infections caused by carbapenem-resistant organisms, but has led to serious bacterial resistance. Acetylcysteine (NAC) is an approved medication that protects the respiratory tract through antioxidant and anti-inflammato...

Full description

Bibliographic Details
Main Authors: Zeyu Huang, Yijia Han, Xiaotuan Zhang, Yao Sun, Yuzhan Lin, Luozhu Feng, Tieli Zhou, Zhongyong Wang
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Microbiology
Subjects:
Enterobacterales
Ceftazidime-avibactam
Antimicrobial resistance
Acetylcysteine
Online Access:https://doi.org/10.1186/s12866-023-03068-5

Internet

https://doi.org/10.1186/s12866-023-03068-5

Similar Items